RAJAT J KUDCHADKER

TitleProfessor
InstitutionMD Anderson
DepartmentRadiation Physics
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thaker NG, Kudchadker RJ, Incalcaterra JR, Bathala TK, Kaplan RS, Agarwal A, Kuban DA, Frank BD, Das P, Feeley TW, Frank SJ. Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing. Brachytherapy. 2021 Aug 10. PMID: 34389265.
      Citations:    Fields:    
    2. Pollard-Larkin JM, Briere TM, Kudchadker RJ, Sadagopan R, Nitsch PL, Wang XA, Salehpour M, Wang J, Vedam S, Nelson CL, Sahoo N, Zhu XR, Court LE, Balter PA, Robinson IJ, Yang J, Howell RM, Followill DS, Kry S, Beddar SA, Martel MK. Our Experience Leading a Large Medical Physics Practice During the COVID-19 Pandemic. Adv Radiat Oncol. 2021 Jul-Aug; 6(4):100683. PMID: 33824935.
      Citations:    
    3. Sanders JW, Venkatesan AM, Levitt CA, Bathala T, Kudchadker RJ, Tang C, Bruno TL, Starks C, Santiago E, Wells M, Weaver CP, Ma J, Frank SJ. Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):614-625. PMID: 32980498.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    4. Pasalic D, Prajapati S, Ludmir EB, Tang C, Choi S, Kudchadker R, Frank SJ. Outcomes and Toxicities of Proton and Photon Radiation Therapy for Testicular Seminoma. Int J Part Ther. 2020; 7(2):11-20. PMID: 33274253.
      Citations: 1     
    5. Sanders JW, Lewis GD, Thames HD, Kudchadker RJ, Venkatesan AM, Bruno TL, Ma J, Pagel MD, Frank SJ. Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1292-1303. PMID: 32634543.
      Citations: 1     Fields:    Translation:Humans
    6. Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy. 2020 Jul - Aug; 19(4):484-490. PMID: 32402544.
      Citations: 1     Fields:    Translation:Humans
    7. Sanders JW, Fletcher JR, Frank SJ, Liu HL, Johnson JM, Zhou Z, Chen HS, Venkatesan AM, Kudchadker RJ, Pagel MD, Ma J. Deep learning application engine (DLAE): Development and integration of deep learning algorithms in medical imaging. SoftwareX. 2019 Jul-Dec; 10. PMID: 34113706.
      Citations:    
    8. Du W, Gao S, Jiang W, Kudchadker RJ. Independent evaluation of the effectiveness of IsoCal in improving image center accuracy on Varian TrueBeam and Clinac machines. J Appl Clin Med Phys. 2018 Sep; 19(5):483-490. PMID: 29956463.
      Citations: 2     Fields:    
    9. Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA. Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):287-295. PMID: 29913254.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    10. Yan Y, Yang J, Beddar S, Ibbott G, Wen Z, Court LE, Hwang KP, Kadbi M, Krishnan S, Fuller CD, Frank SJ, Yang J, Balter P, Kudchadker RJ, Wang J. A methodology to investigate the impact of image distortions on the radiation dose when using magnetic resonance images for planning. Phys Med Biol. 2018 04 05; 63(8):085005. PMID: 29528037.
      Citations: 6     Fields:    Translation:Humans
    11. Alsanea F, Wootton L, Sahoo N, Kudchadker R, Mahmood U, Beddar S. Exradin W1 plastic scintillation detector for in vivo skin dosimetry in passive scattering proton therapy. Phys Med. 2018 Mar; 47:58-63. PMID: 29609819.
      Citations: 1     Fields:    
    12. Blanchard P, Pugh TJ, Swanson DA, Mahmood U, Chen HC, Wang X, Graber WJ, Kudchadker RJ, Bruno T, Feeley T, Frank SJ. Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study. Brachytherapy. 2018 Mar - Apr; 17(2):265-276. PMID: 29269207.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    13. Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):374-382. PMID: 29229325.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    14. Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer. Brachytherapy. 2017 Jul - Aug; 16(4):790-796. PMID: 28442277.
      Citations: 1     Fields:    
    15. Ma J, Moerland MA, Venkatesan AM, Bathala TK, Kudchadker RJ, Brock KK, Frank SJ. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachytherapy. 2017 Jul - Aug; 16(4):743-753. PMID: 28063817.
      Citations: 2     Fields:    
    16. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28396178.
      Citations: 3     Fields:    
    17. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30106637.
      Citations: 25     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    18. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30737827.
      Citations: 5     Fields:    Translation:Humans
    19. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 31812590.
      Citations:    Fields:    Translation:Humans
    20. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 29169971.
      Citations: 3     Fields:    Translation:Humans
    21. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28284511.
      Citations:    Fields:    
    22. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28501429.
      Citations:    Fields:    
    23. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 28517157.
      Citations:    Fields:    
    24. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27370146.
      Citations: 7     Fields:    Translation:Humans
    25. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 27635624.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    26. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23180976.
      Citations: 7     Fields:    
    27. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24674406.
      Citations: 1     Fields:    
    28. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32682778.
      Citations:    Fields:    Translation:HumansPHPublic Health
    29. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 32952054.
      Citations:    Fields:    Translation:Humans
    30. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 33132070.
      Citations:    Fields:    Translation:Humans
    31. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17980822.
      Citations:    Fields:    Translation:Humans
    32. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15234060.
      Citations: 6     Fields:    Translation:Humans
    33. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21296031.
      Citations: 1     Fields:    Translation:Humans
    34. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21844859.
      Citations: 7     Fields:    Translation:Humans
    35. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23102837.
      Citations: 13     Fields:    Translation:Humans
    36. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 22673704.
      Citations: 5     Fields:    Translation:Humans
    37. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23635262.
      Citations: 4     Fields:    Translation:Humans
    38. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23380383.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    39. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23466360.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    40. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 23346126.
      Citations: 2     
    41. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 10659757.
      Citations: 8     Fields:    Translation:Humans
    42. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21799236.
      Citations: 7     Fields:    Translation:Humans
    43. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14604422.
      Citations: 20     Fields:    Translation:Humans
    44. Cardenas CE, Nitsch PL, Kudchadker RJ, Howell RM, Kry SF. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. J Appl Clin Med Phys. 2016 07 08; 17(4):442-455. PMID: 27455499.
      Citations: 3     Fields:    Translation:Humans
    45. Lim TY, Kudchadker RJ, Wang J, Bathala T, Szklaruk J, Pugh TJ, Mahmood U, Ibbott GS, Frank SJ. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience. J Contemp Brachytherapy. 2016 Jun; 8(3):235-42. PMID: 27504133.
      Citations: 4     
    46. Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy. 2016 May-Jun; 15(3):274-282. PMID: 26916105.
      Citations: 5     Fields:    Translation:Humans
    47. Du W, Johnson JL, Jiang W, Kudchadker RJ. On the selection of gantry and collimator angles for isocenter localization using Winston-Lutz tests. J Appl Clin Med Phys. 2016 01 08; 17(1):167-178. PMID: 26894350.
      Citations: 9     Fields:    Translation:Humans
    48. Yu ZH, Kudchadker R, Dong L, Zhang Y, Court LE, Mourtada F, Yock A, Tucker SL, Yang J. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. J Appl Clin Med Phys. 2016 01 08; 17(1):246-258. PMID: 26894362.
      Citations: 3     Fields:    Translation:Humans
    49. Dhanesar SK, Lim TY, Du W, Bruno TL, Frank SJ, Kudchadker RJ. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy. J Appl Clin Med Phys. 2015 09 08; 16(5):62–75. PMID: 26699290.
      Citations: 4     Fields:    Translation:Humans
    50. Pugh TJ, Mahmood U, Swanson DA, Munsell MF, Wang R, Kudchadker RJ, Bruno TL, Frank SJ. Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil. Brachytherapy. 2015 Mar-Apr; 14(2):160-5. PMID: 25255712.
      Citations: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    51. Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ. Establishing high-quality prostate brachytherapy using a phantom simulator training program. Int J Radiat Oncol Biol Phys. 2014 Nov 01; 90(3):579-86. PMID: 25151539.
      Citations: 7     Fields:    Translation:Humans
    52. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Forecasting longitudinal changes in oropharyngeal tumor morphology throughout the course of head and neck radiation therapy. Med Phys. 2014 Aug; 41(8):081708. PMID: 25086518.
      Citations: 1     Fields:    Translation:Humans
    53. Yock AD, Rao A, Dong L, Beadle BM, Garden AS, Kudchadker RJ, Court LE. Predicting oropharyngeal tumor volume throughout the course of radiation therapy from pretreatment computed tomography data using general linear models. Med Phys. 2014 May; 41(5):051705. PMID: 24784371.
      Citations: 2     Fields:    Translation:Humans
    54. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol. 2014 May 21; 59(10):2505-16. PMID: 24778352.
      Citations: 6     Fields:    Translation:Humans
    55. Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e239-46. PMID: 25407875.
      Citations: 7     Fields:    Translation:Humans
    56. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys. 2014 Apr 01; 88(5):1074-84. PMID: 24661661.
      Citations: 40     Fields:    Translation:HumansPHPublic Health
    57. Gossman MS, Hancock SS, Kudchadker RJ, Lundahl PR, Cao M, Melhus CS. Brachytherapy dose-volume histogram commissioning with multiple planning systems. J Appl Clin Med Phys. 2014 Mar 06; 15(2):4620. PMID: 24710449.
      Citations: 4     Fields:    Translation:Humans
    58. Du W, Cho SH, Zhang X, Hoffman KE, Kudchadker RJ. Quantification of beam complexity in intensity-modulated radiation therapy treatment plans. Med Phys. 2014 Feb; 41(2):021716. PMID: 24506607.
      Citations: 30     Fields:    Translation:Humans
    59. Wootton L, Kudchadker R, Lee A, Beddar S. Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer. Phys Med Biol. 2014 Feb 07; 59(3):647-60. PMID: 24434775.
      Citations: 10     Fields:    Translation:Humans
    60. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis. 2013 Dec; 16(4):346-51. PMID: 23939133.
      Citations: 1     Fields:    Translation:Humans
    61. Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A fully automated method for CT-on-rails-guided online adaptive planning for prostate cancer intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):835-41. PMID: 23726001.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    62. Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy. 2014 Jan-Feb; 13(1):68-74. PMID: 23669149.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    63. Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ. Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer. Med Dosim. 2013; 38(3):251-4. PMID: 23540491.
      Citations: 2     Fields:    Translation:Humans
    64. Wootton LS, Kudchadker RJ, Beddar AS, Lee AK. Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy. J Appl Clin Med Phys. 2012 Sep 06; 13(5):3945. PMID: 22955660.
      Citations: 1     Fields:    Translation:Humans
    65. Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1169-78. PMID: 22704703.
      Citations: 39     Fields:    Translation:Humans
    66. Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy. 2013 Jan-Feb; 12(1):30-7. PMID: 22727474.
      Citations: 10     Fields:    Translation:Humans
    67. Yang M, Du W, Frank S, Pugh T, Bruno T, Kudchadker R. SU-E-T-260: Radiation Exposure Estimation for 131Cs Prostate Implant Patient Release Determination. Med Phys. 2012 Jun; 39(6Part13):3763. PMID: 28517343.
      Citations:    Fields:    
    68. Kudchadker RJ, Pugh TJ, Swanson DA, Bruno TL, Bolukbasi Y, Frank SJ. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy. Med Dosim. 2012; 37(4):387-90. PMID: 22560295.
      Citations: 3     Fields:    Translation:Humans
    69. Du W, Gao S, Wang X, Kudchadker RJ. Quantifying the gantry sag on linear accelerators and introducing an MLC-based compensation strategy. Med Phys. 2012 Apr; 39(4):2156-62. PMID: 22482636.
      Citations: 12     Fields:    
    70. Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):e765-71. PMID: 22300559.
      Citations: 3     Fields:    Translation:Humans
    71. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol. 2012 Jul-Sep; 2(3):e7-e13. PMID: 24674130.
      Citations: 4     Fields:    
    72. Kim MM, Kudchadker RJ, Kanke JE, Zhang S, Perkins GH. Bolus electron conformal therapy for the treatment of recurrent inflammatory breast cancer: a case report. Med Dosim. 2012; 37(2):208-13. PMID: 21978532.
      Citations: 7     Fields:    Translation:Humans
    73. Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med. 2012 Jul; 28(3):240-4. PMID: 21875820.
      Citations: 2     Fields:    Translation:Humans
    74. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, van Vulpen M, Frank SJ. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy. 2011 Sep-Oct; 10(5):401-8. PMID: 21306959.
      Citations: 4     Fields:    Translation:Humans
    75. Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys. 2011 Jan; 38(1):34-9. PMID: 21361172.
      Citations: 1     Fields:    
    76. Sha RL, Reddy PY, Rao R, Muralidhar KR, Kudchadker RJ. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma. Med Dosim. 2011; 36(4):377-82. PMID: 21144733.
      Citations: 1     Fields:    Translation:Humans
    77. Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer. Phys Med Biol. 2010 Dec 07; 55(23):7135-47. PMID: 21076190.
      Citations: 15     Fields:    Translation:Humans
    78. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim. 2011; 36(2):200-5. PMID: 20537886.
      Citations: 10     Fields:    Translation:Humans
    79. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy. Am J Clin Oncol. 2010 Apr; 33(2):173-5. PMID: 20010077.
      Citations: 3     Fields:    Translation:Humans
    80. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology. 2009 Sep; 74(3):601-5. PMID: 19589580.
      Citations: 17     Fields:    Translation:Humans
    81. Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L. Effectiveness of using fewer implanted fiducial markers for prostate target alignment. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1283-9. PMID: 19427750.
      Citations: 11     Fields:    Translation:Humans
    82. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management. Cancer. 2009 May 01; 115(9):1827-39. PMID: 19248043.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    83. Brooks C, Cheung RM, Kudchadker RJ. Intensity-modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study. Med Dosim. 2010; 35(2):87-91. PMID: 19931019.
      Citations: 6     Fields:    Translation:Humans
    84. Zullo JR, Kudchadker RJ, Zhu XR, Sahoo N, Gillin MT. LiF TLD-100 as a dosimeter in high energy proton beam therapy--can it yield accurate results? Med Dosim. 2010; 35(1):63-6. PMID: 19931017.
      Citations: 6     Fields:    
    85. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA. Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy. J Urol. 2009 Apr; 181(4):1658-63; discussion 1663-4. PMID: 19233434.
      Citations: 1     Fields:    Translation:Humans
    86. Weinberg R, Antolak JA, Starkschall G, Kudchadker RJ, White RA, Hogstrom KR. Influence of source parameters on large-field electron beam profiles calculated using Monte Carlo methods. Phys Med Biol. 2009 Jan 07; 54(1):105-16. PMID: 19075360.
      Citations: 3     Fields:    
    87. Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK. Dosimetric changes resulting from patient rotational setup errors in proton therapy prostate plans. Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):40-8. PMID: 19058919.
      Citations: 9     Fields:    Translation:Humans
    88. Nelson C, Balter P, Morice RC, Choi B, Kudchadker RJ, Bucci K, Chang JY, Dong L, Tucker S, Vedam S, Briere T, Starkschall G. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. J Appl Clin Med Phys. 2008 Oct 30; 9(4):110-122. PMID: 19020478.
      Citations: 1     Fields:    Translation:Humans
    89. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):274-80. PMID: 18406891.
      Citations:    Fields:    Translation:Humans
    90. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A novel MRI marker for prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):5-8. PMID: 18406882.
      Citations: 18     Fields:    Translation:Animals
    91. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):623-7. PMID: 18410998.
      Citations: 2     Fields:    Translation:Humans
    92. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):813-20. PMID: 18207664.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    93. Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer? Radiother Oncol. 2007 Nov; 85(2):251-9. PMID: 17892900.
      Citations: 6     Fields:    Translation:Humans
    94. de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1529-36. PMID: 17544595.
      Citations: 8     Fields:    Translation:Humans
    95. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 15; 67(4):1059-65. PMID: 17241755.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    96. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):883-91. PMID: 17011461.
      Citations: 13     Fields:    Translation:Humans
    97. Zullo JR, Bloch C, Chi PC, Kudchadker R. Linearity and uniformity response as an indicator of performance for Agfa ADC-MD10 computed radiography plates. Med Dosim. 2004; 29(2):118-21. PMID: 15191759.
      Citations:    Fields:    Translation:Humans
    98. Kirsner SM, Kudchadker RJ, Prado KL, Ha CS, Wilder RB, Cox JD. Clinical implications of incorporating heterogeneity corrections in mantle field irradiation. Int J Radiat Oncol Biol Phys. 2003 Mar 15; 55(4):1135-42. PMID: 12605993.
      Citations:    Fields:    Translation:Humans
    99. Prado KL, Kirsner SM, Kudchadker RJ, Steadham RE, Lane RG. Enhanced dynamic wedge factors at off-axis points in asymmetric fields. J Appl Clin Med Phys. 2003; 4(1):75-84. PMID: 12540821.
      Citations: 6     Fields:    
    100. Kudchadker RJ, Hogstrom KR, Garden AS, McNeese MD, Boyd RA, Antolak JA. Electron conformal radiotherapy using bolus and intensity modulation. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):1023-37. PMID: 12095572.
      Citations: 16     Fields:    Translation:Humans
    101. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. Journal of Applied Clinical Medical Physics. 17:442-455.
    102. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy. Journal of Applied Clinical Medical Physics. 16:62-75.
    103. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy.
    104. In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiation Measurements. 47:921-929.
    105. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer. American Journal of Clinical Oncology: Cancer Clinical Trials.
    106. Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients. Journal of Contemporary Brachytherapy. 8:233-240.
    107. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachytherapy.
    108. Brachytherapy dose-volume histogram commissioning with multiple planning systems. Journal of Applied Clinical Medical Physics. 15:110-120.
    109. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. Journal of Applied Clinical Medical Physics. 9:110-122.
    110. Erratum. International Journal of Radiation Oncology Biology Physics. 60:350.
    111. On the selection of gantry and collimator angles for isocenter localization using Winston-Lutz tests. Journal of Applied Clinical Medical Physics. 17:167-178.
    112. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Practical Radiation Oncology. 2.
    113. Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy. Journal of Applied Clinical Medical Physics. 13:190-197.
    114. Learning anatomy changes from patient populations to create artificial CT images for voxel-level validation of deformable image registration. Journal of Applied Clinical Medical Physics. 17:246-258.
    115. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Practical Radiation Oncology. 3:329-336.
    116. Thermal neutron flux mapping in a head phantom. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 422:106-110.
    117. Multileaf collimation for electron intensity modulation. 210-213.
    118. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment. Medical Physics. 43:4312-4322.
    119. Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches. Journal of Applied Clinical Medical Physics. 12:23-31.
    KUDCHADKER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (215)
    Explore
    _
    Co-Authors (69)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _